36^th World Congress on Neurorehabilitation October 27-28, 2025 Vancouver, Canada

Dr. Videnovic obtained his M.D at the University of Belgrade School of Medicine, where he subsequently completed an internship in Internal medicine followed by a residency in Anatomic pathology. From 1998 to 2000 he was a postdoctoral fellow in the Department of Pharmacology at the University of Illinois in Chicago, where he worked on the neurobiology of the sleep apnea syndrome. He subsequently moved to the Rush Alzheimer′s Disease Center in Chicago, where he worked on several NIH funded clinical-pathological studies of aging. Dr Videnovic completed an internship in Internal medicine at MCP Hahnemann University Hospital in Philadelphia, and a Neurology residency at Northwestern University Feinberg School of Medicine in Chicago where he served as chief resident. Subsequently he trained in Movement Disorders at Rush University Medical Center in Chicago, and sleep medicine at Northwestern University. He obtained a Master of Science degree in clinical research from the Rush Graduate College in 2007. He was appointed as Assistant Professor of Neurology at Northwestern University Feinberg School of Medicine in July 2007. Dr. Videnovic is a member of the American Academy of Neurology, the Parkinson Study Group, and the American Academy of Sleep Medicine. Dr. Videnovic cares for patients with Parkinson′s disease and various movement disorders. He is a principal investigator and co-investigator on several clinical trials in the field of Parkinson′s disease and movement disorders. His research focuses on sleep dysfunction in neurodegenerative disorders, particularly Parkinson′s disease.

Aleksander research focuses on sleep dysfunction in neurodegenerative disorders, particularly Parkinsons disease.

Dott Federico Bilotta, MD, PhD Full-time Attendant Anesthesiologist, Department of Anesthesiology, Critical Care and Pain Medicine, University of Rome “La Sapienza”, Rome Italy. Full Professor in Clinical Anesthesiology at the Albert Einstein College of Medicine, The Bronx, New York, NY, USA Author of more than 68 indexed papers, Total Impact Factor (2010) >237 Recognition and Awards Bilotta F, Caramia R, Paoloni FP, Delfini R, Rosa G. Safety and Efficacy of Intensive Insulin Therapy in Critical Neurosurgical Patients. Anesthesiology 2009;110(3):611-9. This article was chosen by the American Society of Anesthesiologists for a World Press Release and to provide Continuing Medical Education points in the USA Bilotta F, Doronzio A, Cuzzone V, Caramia R, Rosa G. Early Postoperative Cognitive Recovery and Gas Exchange Patterns After Balanced Anesthesia With Sevoflurane or Desflurane in Overweight and Obese Patients Undergoing Craniotomy: A Prospective Randomized Trial. Journal Neurosurgical Anesthesiology 2009;21(3):207-13. This article was chosen and a summary is reported by Faculty 1000 in Medicine 2009 According Review in Anesthesiology 2009, Borgeat A, Brennan TJ, Elsenach JC. Advancing Medicine in Anesthesiology. Anesthesiology 2009; 111: 1192-96 the paper: “Bilotta F, Caramia R, Paoloni FP, Delfini R, Rosa G. Safety and Efficacy of Intensive Insulin Therapy in Critical Neurosurgical Patients. Anesthesiology 2009;110(3):611-9” has been selected among the 12 more representative articles published in Anesthesiology in 2009. Teaching Award: University of Southern California, The Keck School of Medicine and the Department of Anesthesiology as International Visiting Professor “Outstanding teaching contribution” Journal Club and Grand Rounds Lecture, October 21-22, 2010.

Dott Federico Bilotta research interests are in Neurosurgical Anesthesiology.

Eef Hogervorst did her Ph.D. at Maastricht University in age related cognitive decline and treatment at the Department of Psychiatry and Neuropsychology in 1998. She was subsequently employed at the University of Oxford (Oxford Project to Investigate Memory and Ageing, OPTIMA) as a neuropsychologist and epidemiologist and was awarded several grants and prizes for her research into early diagnoses and risk factors for dementia and cognitive decline. Eef did similar research as a Research Associate Professor at the Donald W. Reynolds Department of Geriatrics (ranked 8th nationally) of the University of Arkansas Medical Sciences and at the University of Cambridge (Department of Psychiatry) as Senior Research Associate, before taking on a Chair in Psychology at Loughborough University which is consistently ranked among the top Universities in the U.K. Eef has set-up collaborations with several large multi-centre observational and treatment studies for age related cognitive decline and dementia (EPIC NORFOLK and MRC CFAS in the U.K. and the H ABC, WHIMS and KEEPS studies in the U.S.A and a large cohort in Indonesia). She studies cross cultural clinical diagnostic accuracy of different types of dementias and has developed and validated a computerized expert system and cognitive test battery for this purpose with Dr Bandelow. Eef is an elected member of the MRC College of Experts for Neuroscience and Mental Health, a member of the European Scientific Referee panel for the European Research Area in Ageing and is often asked to review research proposals (Alzheimer Association, NWO, SPARC etc) and papers in her field (Neurology, JNNP, Arch Neurol, etc). She was invited as a keynote speaker at several conferences (e.g. ICAD). At Oxford Eef was Somerville Junior Research fellow and Blasschko fellow at Linacre College. Eef is an elected young Fellow at the Royal Society of Medicine in London, Editor (Section Head) of the International Faculty 1000, on the editorial board of JAD and has over 100 international peer reviewed publications.

Her research includes the use of standardized questionnaires to investigate risk & protective factors for dementia & age-related cognitive decline which is funded by the Alzheimer’s Research Trust & other bodies, such as the New Dynamics of Ageing. Also involved in exercise, sex steroid and nutritional treatment programs to improve cognitive function & mood in the elderly.

Herbert B. Tanowitz completed his graduation in 1967 from Albert Einstein College of Medicine of Yeshiva University. Later he completed his internship in Bellevue Hospital Center and his fellowship in Albert Einstein College of Medicine. His professional interest are laboratory investigates the pathogenesis of chagasic heart disease, caused by the parasite Trypanosoma cruzi. Chagas’ disease is also an opportunistic infection in HIV/AIDS. We are examining signaling pathways involved in cardiac remodeling as a consequence of the T. cruzi infection. This laboratory is examining the consequences of this infection on cell cycle regulatory proteins (i.e., cyclins) in vitro

Parasitology Chagas disease Cerebral malaria Relationship between obesity and infectious diseases has become an important issue. The adipocyte-derived factor adiponectin has been widely implicated in the pathogenesis of heart disease

Dr.David C. Spray is Research Assistant from Jan 1973 - Jan 1977,Assistant Professor-Jan 1977 - Jan 1981,Associate Professor-Jan 1981 - Jan 1986 & Professor-Jan 1986 - Current in Albert Einstein College of Medicine (AECOM)

Neuroscience, Gap junctions, FRAP, optical monitoring of intracellular ionic activities (especially Ca2+ and propagated Ca2+ waves), patch clamp recording of single channels and whole cell currents and standard molecular biological and immunological methods such as Northern and Western blot analyses, immunostaining and RT-PCR and expression profiling using microarrays.

Professor Joseph Ndung’u is the Head of FIND’s Neglected Tropical Diseases (NTD) programme. He has a degree in veterinary medicine and surgery (BVM) from the University of Nairobi, and a PhD on the immunopathology of human African trypanosomiasis (HAT or sleeping sickness) from the University of Glasgow’s Veterinary School in Scotland. He became a Visiting Professor of the University in 2001, and has held a similar position at the University of Wisconsin, Madison, USA. In 2013, he became a Corresponding Fellow of the Royal Society of Edinburgh (CorrFRSE).

African trypanosomiasis

Dr.Georges E. R. Grau is Professor and Chair of Vascular Immunology, Department of Pathology, School of Medical Sciences, Faculty of Medicine, University of Sydney ,1999 - 2006: Professeur des Universites (Physiologie, section 40), Universite de la Mediterranee ,1998 - 1999: Research Associate, CNRS, Prof. D. Raoult, Marseille ,1997 - 1998: Invited Professor, Department of Pathology, University of Regensburg .

Vascular biology Cerebral malaria Immunopathology of microvascular lesions, particularly of cerebral and pulmonary complications of infectious and auto-immune diseases, especially in cerebral malaria, septic shock and multiple sclerosis.

Dr. Alessandro Landi currently working as Assistant Neurosurgeon in the University of Rome “Sapienza”, and he is the member of AANS, NASS, EANS, AOSpine. Alessandro Landi is the winner of “Research Project” in spinal surgery

Research interets of Alessandro Landi includes Anterior and Posterior spine surgery; cranio-cervical junction surgery, pain therapy; minimally invasive and endoscopic spine surgery; spinalneurooncology, Application of hemocomponents in spine surgery; spine trauma, neurotraumatology, biomolecular research for bone augmentation.

Dr. Joseph Quinn is an Associate Professor of Neurology at Oregon Health and Sciences University and a staff neurologist at the Portland VA Medical Center. He completed his undergraduate studies in Biochemical Sciences at Harvard University, his MD at University of Southern California, his internship at LA County Hospital, and his neurology residency at Oregon Health and Sciences University. He has been on the faculty in Oregon since 1994. With grant support from the NIH and from the VA, he has conducted laboratory and clinical research on a number of such candidate therapies for Alzheimer’s disease, including ginkgo biloba, melatonin, lipoic acid, ibuprofen, resveratrol, coenzyme Q, copper chelation, and the omega 3 fatty acid DHA. His research is described as “translational”, which means Dr Quinn has no original ideas but instead attempts to bring established ideas from the laboratory to clinical trials. In some cases, such as copper chelation therapy, this means conducting animal studies to determine if clinical trials are warranted. In other cases, such as ibuprofen, this means conducting novel pilot clinical trials utilizing surrogate markers of disease in order to determine if a large scale clinical trial is warranted. And in yet other cases, such as a national multi-center trial of DHA , this means designing and supervising a full scale clinical trial based on preclinical animal studies conducted and reported by other investigators. The specific positions held by Dr Quinn to support these research efforts include Biomarker Core Leader, Associate Clinical Core Leader, and Clinical Trials director for the NIA-funded Oregon Aging and Alzheimer’s disease center. Dr Quinn is also co-director of the Portland Parkinson’s Disease Research, Education, and Clinical Care Center.

Joseph′s research interests are clinical trials, biomarkers, and animal models in Alzheimer′s disease, and cognitive impairment in Parkinson′s disease.

Dr. Valeria Drago is an Italian Neurologist. She graduated at University of Messina School of Medicine in 2001. In the same institution she took her residency (cum laude) in Neurology. She has done a three year fellowship in Behavioral Neurology with Dr. Kenneth Heilman at University of Florida, College of Medicine, Gainesville, FL, USA where she joined the faculty as a full time Adjunct Assistant Professor (2006-2010). She came back to Italy on January 2010 and she is currently holding a research position at the Center Fatebenefratelli in Brescia (Italy), and a courtesy appointment at UF as Adjunct Assistant Professor. She has several national and international collaborations including the department of Neurology at University of Bologna where she is currently at her 3rd year of Ph.D. The majority of her research has been devoted to investigate attention and creativity in degenerative diseases, particularly Alzheimer′s and Parkinson′s diseases.

Valeria Dragos research has been devoted to investigate attention and creativity in degenerative diseases, particularly Alzheimer′s and Parkinson′s diseases.

Stephen did his B.A. Cornell University, College of Arts and Sciences, Ithaca, NY (Psychology). Ph.D. Mt. Sinai Medical Center, New York, NY (Neuroscience).

Stephens interests include neurodegeneration, single cell RNA analysis, and lesion induced synaptic plasticity.

Yasumasa Graduated in Kyushu University School of Medicine, Fukuoka, Japan, Resident, Department of Neurology, Kyushu University Hospital Neurologist, National Beppu Hospital, Oita, Japan, Research fellow, National Institute of Neuroscience, NCNP, Tokyo, Resident, Department of Neurology, Kyushu University Hospital, Visiting Scientist, Case Western Reserve University, Cleveland, OH, USA, Visiting Scientist, Mayo Clinic Jacksonville, Jacksonville, FL, USA, Neurologist, Department of Neurology, Iizuka Hospital, Fukuoka, Research Associate, Department of Neurology, Kyushu University, Assistant Professor, Department of Neurology, Kyushu University, Associate Professor, Department of Neurology, Kyushu University

Yasumasa′s Research interests include Neurology, Neurobiology, Neurochemistry, Neuroimmunology, Research area: Cell Biology, Pharmacology, Biochemistry in Alzheimer research.